Pharmaceutical Quality Surveillance Program (14of33) Quality - Oct. 16-17, 2019

Cindy Buhse, director of CDER OPQ’s Office of Quality Surveillance, shares an overview of FDA’s pharmaceutical quality surveillance program and the various data sources FDA uses for post-marketing surveillance activities.
Learn more at: www.fda.gov/dr...
_______________________________
FDA CDER’s Small Business and Industry Assistance (SBIA) educates and provides assistance in understanding the regulatory aspects of human drug products & clinical research.
Visit www.fda.gov/cd... and www.fda.gov/cd... for news and a repository of training activities.
Email: [e-mail]
Phone: [phone] I [phone]
LinkedIn: / cder-small-business-an...
Twitter: / fda_drug_info
CDER small business e-mail update subscription: updates.fda.go...